BIOMEDICINE & PHARMACOTHERAPY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1212093, encodeId=9bb612120939c, content=审稿速度:2.0 经验分享：3.12 投稿 3.15 with editor 3.18 under review 3.24 revise 3.29 返稿 4.7 revise 4.13 返稿 4.17 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=39, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c2a75489889, createdName=奶油, createdTime=Mon Apr 18 08:37:54 CST 2022, time=2022-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805409, encodeId=2bbc805409b7, content=接收一篇综述，分享审稿流程，仅供参考！ 2020/05/13 投稿 2020/06/18 一审意见，整体小修 2020/06/24 修改返回 2020/07/01 二审意见 2020/07/02 小修返回 2020/07/03 接收 2020/07/07 交纳版面费2660美元 2020/07/08 清样 2020/07/09 在线 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200731/0b88510053b3412fb53c2a1592a04746/651856a0b0b74148a42e8c58f9c83c11.jpg, createdBy=e2832444513, createdName=Xiaoganglufei, createdTime=Fri Jul 31 17:15:45 CST 2020, time=2020-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224746, encodeId=7b5d1224e4638, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;代谢;综述 经验分享：投了一篇肿瘤代谢重编程的综述，让补充每个作者的机构邮箱地址，没有，就在手稿最后把所有作者的个人邮箱补充上投稿了，还在编辑哪里，还没送外审，再等等吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ea06468665, createdName=ms9000002048223073, createdTime=Mon Jun 06 15:34:03 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224923, encodeId=a6431224923fa, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：中药单体 经验分享：4.07投稿，4.11被拒，编辑发了封邮件说是格式有问题，建议修改重投。后面换了个杂志因为审稿人意见分歧被拒，又重新投这个杂志。重新上传了WB 3次原始数据后重投，5.04投稿，5.19修回，1个审稿人1个问题，给了20天时间修，6.06返修，6.07接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Tue Jun 07 10:20:45 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148772, encodeId=28a62148e7241, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：癌症 经验分享：最近慢了吗？投稿12天了，还是提交到杂志社，咋回事？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ea06468665, createdName=小中医7519, createdTime=Wed Jul 19 12:19:22 CST 2023, time=2023-07-19, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2160809, encodeId=903f216080972, content=研究方向：细胞治疗相关综述 0912 submit 1002 with editor 最近真有点慢哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f84d5486747, createdName=ms6000002140643083, createdTime=Wed Oct 04 00:05:58 CST 2023, time=2023-10-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2181212, encodeId=d53f218121269, content=半个月亮了，还是submitted to journal，小伙伴们最近都是多久送审的😭等毕业的人哭死了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5cef9132291, createdName=ms4000001693181545, createdTime=Sat Jan 13 12:36:05 CST 2024, time=2024-01-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2171258, encodeId=f6fa21e125897, content=submittied to journal一个月了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57b52361759, createdName=122d21b1m83(暂无昵称), createdTime=Mon Nov 27 12:56:00 CST 2023, time=2023-11-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1229940, encodeId=e14c1229940fd, content=偏重的研究方向：中药;综述 经验分享：请问一下，这个杂志需要的机构邮箱该怎么弄啊。期待各位老师的回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4bc6441444, createdName=酷宝, createdTime=Fri Jul 01 14:33:24 CST 2022, time=2022-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2162033, encodeId=94302162033c1, content=偏重的研究方向：心血管 经验分享：9.18投稿的，到现在22天过去了，还是submitted to journal。怎么这么慢啊..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200705/c103783a7e594e719be7741e4f000708/cd994ecd1c9544d1b773484a44f2b724.jpg, createdBy=d2ab5392648, createdName=naughtyyyy, createdTime=Tue Oct 10 19:23:48 CST 2023, time=2023-10-10, status=1, ipAttribution=北京)]

2022-04-18 奶油

审稿速度:2.0
经验分享：3.12 投稿
3.15 with editor
3.18 under review
3.24 revise
3.29 返稿
4.7 revise
4.13 返稿
4.17 accept

193 39

展开39条回复

[GetPortalCommentsPageByObjectIdResponse(id=1212093, encodeId=9bb612120939c, content=审稿速度:2.0 经验分享：3.12 投稿 3.15 with editor 3.18 under review 3.24 revise 3.29 返稿 4.7 revise 4.13 返稿 4.17 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=39, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c2a75489889, createdName=奶油, createdTime=Mon Apr 18 08:37:54 CST 2022, time=2022-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805409, encodeId=2bbc805409b7, content=接收一篇综述，分享审稿流程，仅供参考！ 2020/05/13 投稿 2020/06/18 一审意见，整体小修 2020/06/24 修改返回 2020/07/01 二审意见 2020/07/02 小修返回 2020/07/03 接收 2020/07/07 交纳版面费2660美元 2020/07/08 清样 2020/07/09 在线 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200731/0b88510053b3412fb53c2a1592a04746/651856a0b0b74148a42e8c58f9c83c11.jpg, createdBy=e2832444513, createdName=Xiaoganglufei, createdTime=Fri Jul 31 17:15:45 CST 2020, time=2020-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224746, encodeId=7b5d1224e4638, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;代谢;综述 经验分享：投了一篇肿瘤代谢重编程的综述，让补充每个作者的机构邮箱地址，没有，就在手稿最后把所有作者的个人邮箱补充上投稿了，还在编辑哪里，还没送外审，再等等吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ea06468665, createdName=ms9000002048223073, createdTime=Mon Jun 06 15:34:03 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224923, encodeId=a6431224923fa, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：中药单体 经验分享：4.07投稿，4.11被拒，编辑发了封邮件说是格式有问题，建议修改重投。后面换了个杂志因为审稿人意见分歧被拒，又重新投这个杂志。重新上传了WB 3次原始数据后重投，5.04投稿，5.19修回，1个审稿人1个问题，给了20天时间修，6.06返修，6.07接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Tue Jun 07 10:20:45 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148772, encodeId=28a62148e7241, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：癌症 经验分享：最近慢了吗？投稿12天了，还是提交到杂志社，咋回事？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ea06468665, createdName=小中医7519, createdTime=Wed Jul 19 12:19:22 CST 2023, time=2023-07-19, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2160809, encodeId=903f216080972, content=研究方向：细胞治疗相关综述 0912 submit 1002 with editor 最近真有点慢哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f84d5486747, createdName=ms6000002140643083, createdTime=Wed Oct 04 00:05:58 CST 2023, time=2023-10-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2181212, encodeId=d53f218121269, content=半个月亮了，还是submitted to journal，小伙伴们最近都是多久送审的😭等毕业的人哭死了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5cef9132291, createdName=ms4000001693181545, createdTime=Sat Jan 13 12:36:05 CST 2024, time=2024-01-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2171258, encodeId=f6fa21e125897, content=submittied to journal一个月了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57b52361759, createdName=122d21b1m83(暂无昵称), createdTime=Mon Nov 27 12:56:00 CST 2023, time=2023-11-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1229940, encodeId=e14c1229940fd, content=偏重的研究方向：中药;综述 经验分享：请问一下，这个杂志需要的机构邮箱该怎么弄啊。期待各位老师的回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4bc6441444, createdName=酷宝, createdTime=Fri Jul 01 14:33:24 CST 2022, time=2022-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2162033, encodeId=94302162033c1, content=偏重的研究方向：心血管 经验分享：9.18投稿的，到现在22天过去了，还是submitted to journal。怎么这么慢啊..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200705/c103783a7e594e719be7741e4f000708/cd994ecd1c9544d1b773484a44f2b724.jpg, createdBy=d2ab5392648, createdName=naughtyyyy, createdTime=Tue Oct 10 19:23:48 CST 2023, time=2023-10-10, status=1, ipAttribution=北京)]

2020-07-31 Xiaoganglufei

接收一篇综述，分享审稿流程，仅供参考！
2020/05/13 投稿
2020/06/18 一审意见，整体小修
2020/06/24 修改返回
2020/07/01 二审意见
2020/07/02 小修返回
2020/07/03 接收
2020/07/07 交纳版面费2660美元
2020/07/08 清样
2020/07/09 在线

303 26

展开26条回复

[GetPortalCommentsPageByObjectIdResponse(id=1212093, encodeId=9bb612120939c, content=审稿速度:2.0 经验分享：3.12 投稿 3.15 with editor 3.18 under review 3.24 revise 3.29 返稿 4.7 revise 4.13 返稿 4.17 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=39, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c2a75489889, createdName=奶油, createdTime=Mon Apr 18 08:37:54 CST 2022, time=2022-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805409, encodeId=2bbc805409b7, content=接收一篇综述，分享审稿流程，仅供参考！ 2020/05/13 投稿 2020/06/18 一审意见，整体小修 2020/06/24 修改返回 2020/07/01 二审意见 2020/07/02 小修返回 2020/07/03 接收 2020/07/07 交纳版面费2660美元 2020/07/08 清样 2020/07/09 在线 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200731/0b88510053b3412fb53c2a1592a04746/651856a0b0b74148a42e8c58f9c83c11.jpg, createdBy=e2832444513, createdName=Xiaoganglufei, createdTime=Fri Jul 31 17:15:45 CST 2020, time=2020-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224746, encodeId=7b5d1224e4638, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;代谢;综述 经验分享：投了一篇肿瘤代谢重编程的综述，让补充每个作者的机构邮箱地址，没有，就在手稿最后把所有作者的个人邮箱补充上投稿了，还在编辑哪里，还没送外审，再等等吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ea06468665, createdName=ms9000002048223073, createdTime=Mon Jun 06 15:34:03 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224923, encodeId=a6431224923fa, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：中药单体 经验分享：4.07投稿，4.11被拒，编辑发了封邮件说是格式有问题，建议修改重投。后面换了个杂志因为审稿人意见分歧被拒，又重新投这个杂志。重新上传了WB 3次原始数据后重投，5.04投稿，5.19修回，1个审稿人1个问题，给了20天时间修，6.06返修，6.07接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Tue Jun 07 10:20:45 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148772, encodeId=28a62148e7241, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：癌症 经验分享：最近慢了吗？投稿12天了，还是提交到杂志社，咋回事？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ea06468665, createdName=小中医7519, createdTime=Wed Jul 19 12:19:22 CST 2023, time=2023-07-19, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2160809, encodeId=903f216080972, content=研究方向：细胞治疗相关综述 0912 submit 1002 with editor 最近真有点慢哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f84d5486747, createdName=ms6000002140643083, createdTime=Wed Oct 04 00:05:58 CST 2023, time=2023-10-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2181212, encodeId=d53f218121269, content=半个月亮了，还是submitted to journal，小伙伴们最近都是多久送审的😭等毕业的人哭死了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5cef9132291, createdName=ms4000001693181545, createdTime=Sat Jan 13 12:36:05 CST 2024, time=2024-01-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2171258, encodeId=f6fa21e125897, content=submittied to journal一个月了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57b52361759, createdName=122d21b1m83(暂无昵称), createdTime=Mon Nov 27 12:56:00 CST 2023, time=2023-11-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1229940, encodeId=e14c1229940fd, content=偏重的研究方向：中药;综述 经验分享：请问一下，这个杂志需要的机构邮箱该怎么弄啊。期待各位老师的回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4bc6441444, createdName=酷宝, createdTime=Fri Jul 01 14:33:24 CST 2022, time=2022-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2162033, encodeId=94302162033c1, content=偏重的研究方向：心血管 经验分享：9.18投稿的，到现在22天过去了，还是submitted to journal。怎么这么慢啊..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200705/c103783a7e594e719be7741e4f000708/cd994ecd1c9544d1b773484a44f2b724.jpg, createdBy=d2ab5392648, createdName=naughtyyyy, createdTime=Tue Oct 10 19:23:48 CST 2023, time=2023-10-10, status=1, ipAttribution=北京)]

2022-06-06 ms9000002048223073

审稿速度:2.0 | 投稿命中率:75.0
偏重的研究方向：肿瘤;代谢;综述
经验分享：投了一篇肿瘤代谢重编程的综述，让补充每个作者的机构邮箱地址，没有，就在手稿最后把所有作者的个人邮箱补充上投稿了，还在编辑哪里，还没送外审，再等等吧

154 26

展开26条回复

[GetPortalCommentsPageByObjectIdResponse(id=1212093, encodeId=9bb612120939c, content=审稿速度:2.0 经验分享：3.12 投稿 3.15 with editor 3.18 under review 3.24 revise 3.29 返稿 4.7 revise 4.13 返稿 4.17 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=39, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c2a75489889, createdName=奶油, createdTime=Mon Apr 18 08:37:54 CST 2022, time=2022-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805409, encodeId=2bbc805409b7, content=接收一篇综述，分享审稿流程，仅供参考！ 2020/05/13 投稿 2020/06/18 一审意见，整体小修 2020/06/24 修改返回 2020/07/01 二审意见 2020/07/02 小修返回 2020/07/03 接收 2020/07/07 交纳版面费2660美元 2020/07/08 清样 2020/07/09 在线 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200731/0b88510053b3412fb53c2a1592a04746/651856a0b0b74148a42e8c58f9c83c11.jpg, createdBy=e2832444513, createdName=Xiaoganglufei, createdTime=Fri Jul 31 17:15:45 CST 2020, time=2020-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224746, encodeId=7b5d1224e4638, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;代谢;综述 经验分享：投了一篇肿瘤代谢重编程的综述，让补充每个作者的机构邮箱地址，没有，就在手稿最后把所有作者的个人邮箱补充上投稿了，还在编辑哪里，还没送外审，再等等吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ea06468665, createdName=ms9000002048223073, createdTime=Mon Jun 06 15:34:03 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224923, encodeId=a6431224923fa, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：中药单体 经验分享：4.07投稿，4.11被拒，编辑发了封邮件说是格式有问题，建议修改重投。后面换了个杂志因为审稿人意见分歧被拒，又重新投这个杂志。重新上传了WB 3次原始数据后重投，5.04投稿，5.19修回，1个审稿人1个问题，给了20天时间修，6.06返修，6.07接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Tue Jun 07 10:20:45 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148772, encodeId=28a62148e7241, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：癌症 经验分享：最近慢了吗？投稿12天了，还是提交到杂志社，咋回事？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ea06468665, createdName=小中医7519, createdTime=Wed Jul 19 12:19:22 CST 2023, time=2023-07-19, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2160809, encodeId=903f216080972, content=研究方向：细胞治疗相关综述 0912 submit 1002 with editor 最近真有点慢哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f84d5486747, createdName=ms6000002140643083, createdTime=Wed Oct 04 00:05:58 CST 2023, time=2023-10-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2181212, encodeId=d53f218121269, content=半个月亮了，还是submitted to journal，小伙伴们最近都是多久送审的😭等毕业的人哭死了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5cef9132291, createdName=ms4000001693181545, createdTime=Sat Jan 13 12:36:05 CST 2024, time=2024-01-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2171258, encodeId=f6fa21e125897, content=submittied to journal一个月了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57b52361759, createdName=122d21b1m83(暂无昵称), createdTime=Mon Nov 27 12:56:00 CST 2023, time=2023-11-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1229940, encodeId=e14c1229940fd, content=偏重的研究方向：中药;综述 经验分享：请问一下，这个杂志需要的机构邮箱该怎么弄啊。期待各位老师的回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4bc6441444, createdName=酷宝, createdTime=Fri Jul 01 14:33:24 CST 2022, time=2022-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2162033, encodeId=94302162033c1, content=偏重的研究方向：心血管 经验分享：9.18投稿的，到现在22天过去了，还是submitted to journal。怎么这么慢啊..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200705/c103783a7e594e719be7741e4f000708/cd994ecd1c9544d1b773484a44f2b724.jpg, createdBy=d2ab5392648, createdName=naughtyyyy, createdTime=Tue Oct 10 19:23:48 CST 2023, time=2023-10-10, status=1, ipAttribution=北京)]

2022-06-07 小胖子罗军

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：中药单体
经验分享：4.07投稿，4.11被拒，编辑发了封邮件说是格式有问题，建议修改重投。后面换了个杂志因为审稿人意见分歧被拒，又重新投这个杂志。重新上传了WB 3次原始数据后重投，5.04投稿，5.19修回，1个审稿人1个问题，给了20天时间修，6.06返修，6.07接受

113 22

展开22条回复

[GetPortalCommentsPageByObjectIdResponse(id=1212093, encodeId=9bb612120939c, content=审稿速度:2.0 经验分享：3.12 投稿 3.15 with editor 3.18 under review 3.24 revise 3.29 返稿 4.7 revise 4.13 返稿 4.17 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=39, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c2a75489889, createdName=奶油, createdTime=Mon Apr 18 08:37:54 CST 2022, time=2022-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805409, encodeId=2bbc805409b7, content=接收一篇综述，分享审稿流程，仅供参考！ 2020/05/13 投稿 2020/06/18 一审意见，整体小修 2020/06/24 修改返回 2020/07/01 二审意见 2020/07/02 小修返回 2020/07/03 接收 2020/07/07 交纳版面费2660美元 2020/07/08 清样 2020/07/09 在线 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200731/0b88510053b3412fb53c2a1592a04746/651856a0b0b74148a42e8c58f9c83c11.jpg, createdBy=e2832444513, createdName=Xiaoganglufei, createdTime=Fri Jul 31 17:15:45 CST 2020, time=2020-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224746, encodeId=7b5d1224e4638, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;代谢;综述 经验分享：投了一篇肿瘤代谢重编程的综述，让补充每个作者的机构邮箱地址，没有，就在手稿最后把所有作者的个人邮箱补充上投稿了，还在编辑哪里，还没送外审，再等等吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ea06468665, createdName=ms9000002048223073, createdTime=Mon Jun 06 15:34:03 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224923, encodeId=a6431224923fa, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：中药单体 经验分享：4.07投稿，4.11被拒，编辑发了封邮件说是格式有问题，建议修改重投。后面换了个杂志因为审稿人意见分歧被拒，又重新投这个杂志。重新上传了WB 3次原始数据后重投，5.04投稿，5.19修回，1个审稿人1个问题，给了20天时间修，6.06返修，6.07接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Tue Jun 07 10:20:45 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148772, encodeId=28a62148e7241, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：癌症 经验分享：最近慢了吗？投稿12天了，还是提交到杂志社，咋回事？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ea06468665, createdName=小中医7519, createdTime=Wed Jul 19 12:19:22 CST 2023, time=2023-07-19, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2160809, encodeId=903f216080972, content=研究方向：细胞治疗相关综述 0912 submit 1002 with editor 最近真有点慢哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f84d5486747, createdName=ms6000002140643083, createdTime=Wed Oct 04 00:05:58 CST 2023, time=2023-10-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2181212, encodeId=d53f218121269, content=半个月亮了，还是submitted to journal，小伙伴们最近都是多久送审的😭等毕业的人哭死了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5cef9132291, createdName=ms4000001693181545, createdTime=Sat Jan 13 12:36:05 CST 2024, time=2024-01-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2171258, encodeId=f6fa21e125897, content=submittied to journal一个月了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57b52361759, createdName=122d21b1m83(暂无昵称), createdTime=Mon Nov 27 12:56:00 CST 2023, time=2023-11-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1229940, encodeId=e14c1229940fd, content=偏重的研究方向：中药;综述 经验分享：请问一下，这个杂志需要的机构邮箱该怎么弄啊。期待各位老师的回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4bc6441444, createdName=酷宝, createdTime=Fri Jul 01 14:33:24 CST 2022, time=2022-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2162033, encodeId=94302162033c1, content=偏重的研究方向：心血管 经验分享：9.18投稿的，到现在22天过去了，还是submitted to journal。怎么这么慢啊..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200705/c103783a7e594e719be7741e4f000708/cd994ecd1c9544d1b773484a44f2b724.jpg, createdBy=d2ab5392648, createdName=naughtyyyy, createdTime=Tue Oct 10 19:23:48 CST 2023, time=2023-10-10, status=1, ipAttribution=北京)]

2023-07-19 小中医7519 来自天津

审稿速度:2.0 | 投稿命中率:75.0
偏重的研究方向：癌症
经验分享：最近慢了吗？投稿12天了，还是提交到杂志社，咋回事？

50 21

展开21条回复

[GetPortalCommentsPageByObjectIdResponse(id=1212093, encodeId=9bb612120939c, content=审稿速度:2.0 经验分享：3.12 投稿 3.15 with editor 3.18 under review 3.24 revise 3.29 返稿 4.7 revise 4.13 返稿 4.17 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=39, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c2a75489889, createdName=奶油, createdTime=Mon Apr 18 08:37:54 CST 2022, time=2022-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805409, encodeId=2bbc805409b7, content=接收一篇综述，分享审稿流程，仅供参考！ 2020/05/13 投稿 2020/06/18 一审意见，整体小修 2020/06/24 修改返回 2020/07/01 二审意见 2020/07/02 小修返回 2020/07/03 接收 2020/07/07 交纳版面费2660美元 2020/07/08 清样 2020/07/09 在线 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200731/0b88510053b3412fb53c2a1592a04746/651856a0b0b74148a42e8c58f9c83c11.jpg, createdBy=e2832444513, createdName=Xiaoganglufei, createdTime=Fri Jul 31 17:15:45 CST 2020, time=2020-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224746, encodeId=7b5d1224e4638, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;代谢;综述 经验分享：投了一篇肿瘤代谢重编程的综述，让补充每个作者的机构邮箱地址，没有，就在手稿最后把所有作者的个人邮箱补充上投稿了，还在编辑哪里，还没送外审，再等等吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ea06468665, createdName=ms9000002048223073, createdTime=Mon Jun 06 15:34:03 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224923, encodeId=a6431224923fa, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：中药单体 经验分享：4.07投稿，4.11被拒，编辑发了封邮件说是格式有问题，建议修改重投。后面换了个杂志因为审稿人意见分歧被拒，又重新投这个杂志。重新上传了WB 3次原始数据后重投，5.04投稿，5.19修回，1个审稿人1个问题，给了20天时间修，6.06返修，6.07接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Tue Jun 07 10:20:45 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148772, encodeId=28a62148e7241, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：癌症 经验分享：最近慢了吗？投稿12天了，还是提交到杂志社，咋回事？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ea06468665, createdName=小中医7519, createdTime=Wed Jul 19 12:19:22 CST 2023, time=2023-07-19, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2160809, encodeId=903f216080972, content=研究方向：细胞治疗相关综述 0912 submit 1002 with editor 最近真有点慢哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f84d5486747, createdName=ms6000002140643083, createdTime=Wed Oct 04 00:05:58 CST 2023, time=2023-10-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2181212, encodeId=d53f218121269, content=半个月亮了，还是submitted to journal，小伙伴们最近都是多久送审的😭等毕业的人哭死了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5cef9132291, createdName=ms4000001693181545, createdTime=Sat Jan 13 12:36:05 CST 2024, time=2024-01-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2171258, encodeId=f6fa21e125897, content=submittied to journal一个月了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57b52361759, createdName=122d21b1m83(暂无昵称), createdTime=Mon Nov 27 12:56:00 CST 2023, time=2023-11-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1229940, encodeId=e14c1229940fd, content=偏重的研究方向：中药;综述 经验分享：请问一下，这个杂志需要的机构邮箱该怎么弄啊。期待各位老师的回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4bc6441444, createdName=酷宝, createdTime=Fri Jul 01 14:33:24 CST 2022, time=2022-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2162033, encodeId=94302162033c1, content=偏重的研究方向：心血管 经验分享：9.18投稿的，到现在22天过去了，还是submitted to journal。怎么这么慢啊..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200705/c103783a7e594e719be7741e4f000708/cd994ecd1c9544d1b773484a44f2b724.jpg, createdBy=d2ab5392648, createdName=naughtyyyy, createdTime=Tue Oct 10 19:23:48 CST 2023, time=2023-10-10, status=1, ipAttribution=北京)]

2023-10-04 ms6000002140643083 来自安徽省

研究方向：细胞治疗相关综述
0912 submit
1002 with editor
最近真有点慢哦

32 19

展开19条回复

[GetPortalCommentsPageByObjectIdResponse(id=1212093, encodeId=9bb612120939c, content=审稿速度:2.0 经验分享：3.12 投稿 3.15 with editor 3.18 under review 3.24 revise 3.29 返稿 4.7 revise 4.13 返稿 4.17 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=39, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c2a75489889, createdName=奶油, createdTime=Mon Apr 18 08:37:54 CST 2022, time=2022-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805409, encodeId=2bbc805409b7, content=接收一篇综述，分享审稿流程，仅供参考！ 2020/05/13 投稿 2020/06/18 一审意见，整体小修 2020/06/24 修改返回 2020/07/01 二审意见 2020/07/02 小修返回 2020/07/03 接收 2020/07/07 交纳版面费2660美元 2020/07/08 清样 2020/07/09 在线 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200731/0b88510053b3412fb53c2a1592a04746/651856a0b0b74148a42e8c58f9c83c11.jpg, createdBy=e2832444513, createdName=Xiaoganglufei, createdTime=Fri Jul 31 17:15:45 CST 2020, time=2020-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224746, encodeId=7b5d1224e4638, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;代谢;综述 经验分享：投了一篇肿瘤代谢重编程的综述，让补充每个作者的机构邮箱地址，没有，就在手稿最后把所有作者的个人邮箱补充上投稿了，还在编辑哪里，还没送外审，再等等吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ea06468665, createdName=ms9000002048223073, createdTime=Mon Jun 06 15:34:03 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224923, encodeId=a6431224923fa, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：中药单体 经验分享：4.07投稿，4.11被拒，编辑发了封邮件说是格式有问题，建议修改重投。后面换了个杂志因为审稿人意见分歧被拒，又重新投这个杂志。重新上传了WB 3次原始数据后重投，5.04投稿，5.19修回，1个审稿人1个问题，给了20天时间修，6.06返修，6.07接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Tue Jun 07 10:20:45 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148772, encodeId=28a62148e7241, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：癌症 经验分享：最近慢了吗？投稿12天了，还是提交到杂志社，咋回事？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ea06468665, createdName=小中医7519, createdTime=Wed Jul 19 12:19:22 CST 2023, time=2023-07-19, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2160809, encodeId=903f216080972, content=研究方向：细胞治疗相关综述 0912 submit 1002 with editor 最近真有点慢哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f84d5486747, createdName=ms6000002140643083, createdTime=Wed Oct 04 00:05:58 CST 2023, time=2023-10-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2181212, encodeId=d53f218121269, content=半个月亮了，还是submitted to journal，小伙伴们最近都是多久送审的😭等毕业的人哭死了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5cef9132291, createdName=ms4000001693181545, createdTime=Sat Jan 13 12:36:05 CST 2024, time=2024-01-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2171258, encodeId=f6fa21e125897, content=submittied to journal一个月了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57b52361759, createdName=122d21b1m83(暂无昵称), createdTime=Mon Nov 27 12:56:00 CST 2023, time=2023-11-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1229940, encodeId=e14c1229940fd, content=偏重的研究方向：中药;综述 经验分享：请问一下，这个杂志需要的机构邮箱该怎么弄啊。期待各位老师的回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4bc6441444, createdName=酷宝, createdTime=Fri Jul 01 14:33:24 CST 2022, time=2022-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2162033, encodeId=94302162033c1, content=偏重的研究方向：心血管 经验分享：9.18投稿的，到现在22天过去了，还是submitted to journal。怎么这么慢啊..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200705/c103783a7e594e719be7741e4f000708/cd994ecd1c9544d1b773484a44f2b724.jpg, createdBy=d2ab5392648, createdName=naughtyyyy, createdTime=Tue Oct 10 19:23:48 CST 2023, time=2023-10-10, status=1, ipAttribution=北京)]

2024-01-13 ms4000001693181545 来自湖北省

半个月亮了，还是submitted to journal，小伙伴们最近都是多久送审的😭等毕业的人哭死了

25 17

展开17条回复

[GetPortalCommentsPageByObjectIdResponse(id=1212093, encodeId=9bb612120939c, content=审稿速度:2.0 经验分享：3.12 投稿 3.15 with editor 3.18 under review 3.24 revise 3.29 返稿 4.7 revise 4.13 返稿 4.17 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=39, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c2a75489889, createdName=奶油, createdTime=Mon Apr 18 08:37:54 CST 2022, time=2022-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805409, encodeId=2bbc805409b7, content=接收一篇综述，分享审稿流程，仅供参考！ 2020/05/13 投稿 2020/06/18 一审意见，整体小修 2020/06/24 修改返回 2020/07/01 二审意见 2020/07/02 小修返回 2020/07/03 接收 2020/07/07 交纳版面费2660美元 2020/07/08 清样 2020/07/09 在线 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200731/0b88510053b3412fb53c2a1592a04746/651856a0b0b74148a42e8c58f9c83c11.jpg, createdBy=e2832444513, createdName=Xiaoganglufei, createdTime=Fri Jul 31 17:15:45 CST 2020, time=2020-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224746, encodeId=7b5d1224e4638, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;代谢;综述 经验分享：投了一篇肿瘤代谢重编程的综述，让补充每个作者的机构邮箱地址，没有，就在手稿最后把所有作者的个人邮箱补充上投稿了，还在编辑哪里，还没送外审，再等等吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ea06468665, createdName=ms9000002048223073, createdTime=Mon Jun 06 15:34:03 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224923, encodeId=a6431224923fa, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：中药单体 经验分享：4.07投稿，4.11被拒，编辑发了封邮件说是格式有问题，建议修改重投。后面换了个杂志因为审稿人意见分歧被拒，又重新投这个杂志。重新上传了WB 3次原始数据后重投，5.04投稿，5.19修回，1个审稿人1个问题，给了20天时间修，6.06返修，6.07接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Tue Jun 07 10:20:45 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148772, encodeId=28a62148e7241, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：癌症 经验分享：最近慢了吗？投稿12天了，还是提交到杂志社，咋回事？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ea06468665, createdName=小中医7519, createdTime=Wed Jul 19 12:19:22 CST 2023, time=2023-07-19, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2160809, encodeId=903f216080972, content=研究方向：细胞治疗相关综述 0912 submit 1002 with editor 最近真有点慢哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f84d5486747, createdName=ms6000002140643083, createdTime=Wed Oct 04 00:05:58 CST 2023, time=2023-10-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2181212, encodeId=d53f218121269, content=半个月亮了，还是submitted to journal，小伙伴们最近都是多久送审的😭等毕业的人哭死了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5cef9132291, createdName=ms4000001693181545, createdTime=Sat Jan 13 12:36:05 CST 2024, time=2024-01-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2171258, encodeId=f6fa21e125897, content=submittied to journal一个月了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57b52361759, createdName=122d21b1m83(暂无昵称), createdTime=Mon Nov 27 12:56:00 CST 2023, time=2023-11-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1229940, encodeId=e14c1229940fd, content=偏重的研究方向：中药;综述 经验分享：请问一下，这个杂志需要的机构邮箱该怎么弄啊。期待各位老师的回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4bc6441444, createdName=酷宝, createdTime=Fri Jul 01 14:33:24 CST 2022, time=2022-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2162033, encodeId=94302162033c1, content=偏重的研究方向：心血管 经验分享：9.18投稿的，到现在22天过去了，还是submitted to journal。怎么这么慢啊..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200705/c103783a7e594e719be7741e4f000708/cd994ecd1c9544d1b773484a44f2b724.jpg, createdBy=d2ab5392648, createdName=naughtyyyy, createdTime=Tue Oct 10 19:23:48 CST 2023, time=2023-10-10, status=1, ipAttribution=北京)]

2023-11-27 122d21b1m83(暂无昵称) 来自上海

submittied to journal一个月了！

61 17

展开17条回复

[GetPortalCommentsPageByObjectIdResponse(id=1212093, encodeId=9bb612120939c, content=审稿速度:2.0 经验分享：3.12 投稿 3.15 with editor 3.18 under review 3.24 revise 3.29 返稿 4.7 revise 4.13 返稿 4.17 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=39, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c2a75489889, createdName=奶油, createdTime=Mon Apr 18 08:37:54 CST 2022, time=2022-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805409, encodeId=2bbc805409b7, content=接收一篇综述，分享审稿流程，仅供参考！ 2020/05/13 投稿 2020/06/18 一审意见，整体小修 2020/06/24 修改返回 2020/07/01 二审意见 2020/07/02 小修返回 2020/07/03 接收 2020/07/07 交纳版面费2660美元 2020/07/08 清样 2020/07/09 在线 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200731/0b88510053b3412fb53c2a1592a04746/651856a0b0b74148a42e8c58f9c83c11.jpg, createdBy=e2832444513, createdName=Xiaoganglufei, createdTime=Fri Jul 31 17:15:45 CST 2020, time=2020-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224746, encodeId=7b5d1224e4638, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;代谢;综述 经验分享：投了一篇肿瘤代谢重编程的综述，让补充每个作者的机构邮箱地址，没有，就在手稿最后把所有作者的个人邮箱补充上投稿了，还在编辑哪里，还没送外审，再等等吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ea06468665, createdName=ms9000002048223073, createdTime=Mon Jun 06 15:34:03 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224923, encodeId=a6431224923fa, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：中药单体 经验分享：4.07投稿，4.11被拒，编辑发了封邮件说是格式有问题，建议修改重投。后面换了个杂志因为审稿人意见分歧被拒，又重新投这个杂志。重新上传了WB 3次原始数据后重投，5.04投稿，5.19修回，1个审稿人1个问题，给了20天时间修，6.06返修，6.07接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Tue Jun 07 10:20:45 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148772, encodeId=28a62148e7241, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：癌症 经验分享：最近慢了吗？投稿12天了，还是提交到杂志社，咋回事？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ea06468665, createdName=小中医7519, createdTime=Wed Jul 19 12:19:22 CST 2023, time=2023-07-19, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2160809, encodeId=903f216080972, content=研究方向：细胞治疗相关综述 0912 submit 1002 with editor 最近真有点慢哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f84d5486747, createdName=ms6000002140643083, createdTime=Wed Oct 04 00:05:58 CST 2023, time=2023-10-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2181212, encodeId=d53f218121269, content=半个月亮了，还是submitted to journal，小伙伴们最近都是多久送审的😭等毕业的人哭死了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5cef9132291, createdName=ms4000001693181545, createdTime=Sat Jan 13 12:36:05 CST 2024, time=2024-01-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2171258, encodeId=f6fa21e125897, content=submittied to journal一个月了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57b52361759, createdName=122d21b1m83(暂无昵称), createdTime=Mon Nov 27 12:56:00 CST 2023, time=2023-11-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1229940, encodeId=e14c1229940fd, content=偏重的研究方向：中药;综述 经验分享：请问一下，这个杂志需要的机构邮箱该怎么弄啊。期待各位老师的回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4bc6441444, createdName=酷宝, createdTime=Fri Jul 01 14:33:24 CST 2022, time=2022-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2162033, encodeId=94302162033c1, content=偏重的研究方向：心血管 经验分享：9.18投稿的，到现在22天过去了，还是submitted to journal。怎么这么慢啊..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200705/c103783a7e594e719be7741e4f000708/cd994ecd1c9544d1b773484a44f2b724.jpg, createdBy=d2ab5392648, createdName=naughtyyyy, createdTime=Tue Oct 10 19:23:48 CST 2023, time=2023-10-10, status=1, ipAttribution=北京)]

2022-07-01 酷宝

偏重的研究方向：中药;综述
经验分享：请问一下，这个杂志需要的机构邮箱该怎么弄啊。期待各位老师的回复

111 17

展开17条回复

[GetPortalCommentsPageByObjectIdResponse(id=1212093, encodeId=9bb612120939c, content=审稿速度:2.0 经验分享：3.12 投稿 3.15 with editor 3.18 under review 3.24 revise 3.29 返稿 4.7 revise 4.13 返稿 4.17 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=39, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c2a75489889, createdName=奶油, createdTime=Mon Apr 18 08:37:54 CST 2022, time=2022-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805409, encodeId=2bbc805409b7, content=接收一篇综述，分享审稿流程，仅供参考！ 2020/05/13 投稿 2020/06/18 一审意见，整体小修 2020/06/24 修改返回 2020/07/01 二审意见 2020/07/02 小修返回 2020/07/03 接收 2020/07/07 交纳版面费2660美元 2020/07/08 清样 2020/07/09 在线 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200731/0b88510053b3412fb53c2a1592a04746/651856a0b0b74148a42e8c58f9c83c11.jpg, createdBy=e2832444513, createdName=Xiaoganglufei, createdTime=Fri Jul 31 17:15:45 CST 2020, time=2020-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224746, encodeId=7b5d1224e4638, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;代谢;综述 经验分享：投了一篇肿瘤代谢重编程的综述，让补充每个作者的机构邮箱地址，没有，就在手稿最后把所有作者的个人邮箱补充上投稿了，还在编辑哪里，还没送外审，再等等吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ea06468665, createdName=ms9000002048223073, createdTime=Mon Jun 06 15:34:03 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224923, encodeId=a6431224923fa, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：中药单体 经验分享：4.07投稿，4.11被拒，编辑发了封邮件说是格式有问题，建议修改重投。后面换了个杂志因为审稿人意见分歧被拒，又重新投这个杂志。重新上传了WB 3次原始数据后重投，5.04投稿，5.19修回，1个审稿人1个问题，给了20天时间修，6.06返修，6.07接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Tue Jun 07 10:20:45 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148772, encodeId=28a62148e7241, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：癌症 经验分享：最近慢了吗？投稿12天了，还是提交到杂志社，咋回事？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ea06468665, createdName=小中医7519, createdTime=Wed Jul 19 12:19:22 CST 2023, time=2023-07-19, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2160809, encodeId=903f216080972, content=研究方向：细胞治疗相关综述 0912 submit 1002 with editor 最近真有点慢哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f84d5486747, createdName=ms6000002140643083, createdTime=Wed Oct 04 00:05:58 CST 2023, time=2023-10-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2181212, encodeId=d53f218121269, content=半个月亮了，还是submitted to journal，小伙伴们最近都是多久送审的😭等毕业的人哭死了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5cef9132291, createdName=ms4000001693181545, createdTime=Sat Jan 13 12:36:05 CST 2024, time=2024-01-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2171258, encodeId=f6fa21e125897, content=submittied to journal一个月了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57b52361759, createdName=122d21b1m83(暂无昵称), createdTime=Mon Nov 27 12:56:00 CST 2023, time=2023-11-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1229940, encodeId=e14c1229940fd, content=偏重的研究方向：中药;综述 经验分享：请问一下，这个杂志需要的机构邮箱该怎么弄啊。期待各位老师的回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4bc6441444, createdName=酷宝, createdTime=Fri Jul 01 14:33:24 CST 2022, time=2022-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2162033, encodeId=94302162033c1, content=偏重的研究方向：心血管 经验分享：9.18投稿的，到现在22天过去了，还是submitted to journal。怎么这么慢啊..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200705/c103783a7e594e719be7741e4f000708/cd994ecd1c9544d1b773484a44f2b724.jpg, createdBy=d2ab5392648, createdName=naughtyyyy, createdTime=Tue Oct 10 19:23:48 CST 2023, time=2023-10-10, status=1, ipAttribution=北京)]

2023-10-10 naughtyyyy 来自北京

偏重的研究方向：心血管
经验分享：9.18投稿的，到现在22天过去了，还是submitted to journal。怎么这么慢啊...

26 16

展开16条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务